A sensitivity enhanced high-performance liquid chromatography fluorescence method for the detection of nephrotoxic and carcinogenic aristolochic acid in herbal medicines

被引:69
作者
Chan, Wan [1 ]
Lee, Kim-Chung [1 ]
Liu, Ning [1 ]
Cai, Zongwei [1 ]
机构
[1] Hong Kong Baptist Univ, Dept Chem, Kowloon, Hong Kong, Peoples R China
关键词
aristolochic acid; pre-column derivatization; high-performance liquid chromatography; fluorescence detection; traditional Chinese medicine;
D O I
10.1016/j.chroma.2007.06.055
中图分类号
Q5 [生物化学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
A new, sensitive and selective HPLC method with fluorescence detector (HPLC-FLD) for the determination of nephrotoxic and carcinogenic aristolochic acid (AA) in herbal medicines by using pre-column derivatization with zinc powder in acetic acid is presented. Variables governing the derivatization reaction, such as the amount of zinc powder and acetic acid, as well as the derivatization time were studied and optimized. An extended linear dynamic range over three orders of magnitude was observed for AA-I and AA-II (R-2 > 0.9998). Method accuracy at low, medium and high spiked AA levels determined by the percentage mean deviation was below 4.4% and 7.2% for AA-I and AA-II, respectively. The detection limits of 0.39 ng/mL (AA-i) and 0.52 ng/mL (AA-II) were 2 orders of magnitude lower than those obtained from HPLC-MS or CE-ECD analyses, 3-4 orders of magnitude lower than those from HPLC-UV or CE-UV methods. The developed method has been applied for the determination of AA in herbal medicines. Among the tested samples, Guanmutong had the highest AA concentration (2607.0 mu g/g AA-I, 711.2 mu g/g AA-II). Comparison studies between HPLC-FLD and HPLC-MS/MS demonstrated that the two methods gave similar quantitative results for the selected herb samples. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:113 / 119
页数:7
相关论文
共 32 条
[1]
Aristolochic acid a risk factor for Balkan endemic nephropathy-associated urothelial cancer? [J].
Arlt, VM ;
Ferluga, D ;
Stiborova, M ;
Pfohl-Leszkowicz, A ;
Vukelic, M ;
Ceovic, S ;
Schmeiser, HH ;
Cosyns, JP .
INTERNATIONAL JOURNAL OF CANCER, 2002, 101 (05) :500-502
[2]
P-32-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy [J].
Bieler, CA ;
Stiborova, M ;
Wiessler, M ;
Cosyns, JP ;
deStrihou, CV ;
Schmeiser, HH .
CARCINOGENESIS, 1997, 18 (05) :1063-1067
[3]
Determination of aristolochic acids in medicinal plant and herbal product by liquid chromatography-electrospray-ion trap mass spectrometry [J].
Chan, SA ;
Chen, MJ ;
Liu, TY ;
Fuh, MR ;
Deng, JF ;
Wu, ML ;
Hsieh, SJ .
TALANTA, 2003, 60 (04) :679-685
[4]
Investigation of the metabolism and reductive activation of carcinogenic aristolochic acids in rats [J].
Chan, Wan ;
Luo, Hai-Bin ;
Zheng, Yufang ;
Cheng, Yuen-Kit ;
Cai, Zongwei .
DRUG METABOLISM AND DISPOSITION, 2007, 35 (06) :866-874
[5]
Liquid chromatography-tandem mass spectrometry analysis of the DNA adducts of aristolochic acids [J].
Chan, Wan ;
Zheng, Yufang ;
Cai, Zongwei .
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY, 2007, 18 (04) :642-650
[6]
Study of the phase I and phase II metabolism of nephrotoxin aristolochic acid by liquid chromatography/tandem mass spectrometry [J].
Chan, Wan ;
Cui, Liang ;
Xu, Guowang ;
Cai, Zongwei .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2006, 20 (11) :1755-1760
[7]
Debelle FD, 2002, J AM SOC NEPHROL, V13, P431, DOI 10.1681/ASN.V132431
[8]
Aristolochic acid, an herbal carcinogen, sold on the Web after FDA alert [J].
Gold, LS ;
Slone, TH .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (16) :1576-1577
[9]
GOLD LS, 1997, HDB CARCINOGENIC POT
[10]
Determination of aristolochic acid in Chinese herbal medicine by capillary electrophoresis with laser-induced fluorescence detection [J].
Hsieh, SC ;
Huang, MF ;
Lin, BS ;
Chang, HT .
JOURNAL OF CHROMATOGRAPHY A, 2006, 1105 (1-2) :127-134